These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 33930618)
1. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients. Bigos R; Solomon E; Dorfman JD; Ha M J Surg Res; 2021 Sep; 265():122-130. PubMed ID: 33930618 [TBL] [Abstract][Full Text] [Related]
2. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma. Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333 [TBL] [Abstract][Full Text] [Related]
3. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma. Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732 [TBL] [Abstract][Full Text] [Related]
4. Weight-Based Enoxaparin Achieves Adequate Anti-Xa Levels More Often in Trauma Patients: A Prospective Study. Stutsrim AE; Eady JM; Collum M; Rebo GJ; Rebo KA; Miller PR; Nunn AM Am Surg; 2021 Jan; 87(1):77-82. PubMed ID: 32915054 [TBL] [Abstract][Full Text] [Related]
5. Achievement of goal anti-Xa activity with weight-based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients. Taylor A; Huang E; Waller J; White C; Martinez-Quinones P; Robinson T Pharmacotherapy; 2021 Jun; 41(6):508-514. PubMed ID: 33864688 [TBL] [Abstract][Full Text] [Related]
6. The ATLANTIC study: Anti-Xa level assessment in trauma intensive care. Rakhra S; Martin EL; Fitzgerald M; Udy A Injury; 2020 Jan; 51(1):10-14. PubMed ID: 31679829 [TBL] [Abstract][Full Text] [Related]
7. Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients. Costantini TW; Min E; Box K; Tran V; Winfield RD; Fortlage D; Doucet J; Bansal V; Coimbra R J Trauma Acute Care Surg; 2013 Jan; 74(1):128-33; discussion 134-5. PubMed ID: 23271087 [TBL] [Abstract][Full Text] [Related]
8. If some is good, more is better: An enoxaparin dosing strategy to improve pharmacologic venous thromboembolism prophylaxis. Berndtson AE; Costantini TW; Lane J; Box K; Coimbra R J Trauma Acute Care Surg; 2016 Dec; 81(6):1095-1100. PubMed ID: 27244575 [TBL] [Abstract][Full Text] [Related]
9. Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients. Thind T; Heye T; Henson C; Reif R; Jensen HK; Kalkwarf KJ; Bhavaraju A; Robertson R; Jenkins A Am Surg; 2024 Jun; 90(6):1406-1411. PubMed ID: 38518208 [TBL] [Abstract][Full Text] [Related]
10. Impact of Weight on Anti-Xa Attainment in High-Risk Trauma Patients on Enoxaparin Chemoprophylaxis. Farrar JE; Droege ME; Philpott CD; Mueller EW; Ernst NE; Makley AT; Deichstetter KM; Droege CA J Surg Res; 2021 Aug; 264():425-434. PubMed ID: 33848842 [TBL] [Abstract][Full Text] [Related]
12. Enoxaparin titrated by anti-Xa levels reduces venous thromboembolism in trauma patients. Gates RS; Lollar DI; Collier BR; Smith J; Faulks ER; Gillen JR J Trauma Acute Care Surg; 2022 Jan; 92(1):93-97. PubMed ID: 34561398 [TBL] [Abstract][Full Text] [Related]
13. Weight-based enoxaparin with anti-factor Xa assay-based dose adjustment for venous thromboembolic event prophylaxis in adult trauma patients results in improved prophylactic range targeting. Rodier SG; Bukur M; Moore S; Frangos SG; Tandon M; DiMaggio CJ; Ayoung-Chee P; Marshall GT Eur J Trauma Emerg Surg; 2021 Feb; 47(1):145-151. PubMed ID: 31471669 [TBL] [Abstract][Full Text] [Related]
14. Prospective Evaluation of Weight-Based Prophylactic Enoxaparin Dosing in Critically Ill Trauma Patients: Adequacy of AntiXa Levels Is Improved. Nunez JM; Becher RD; Rebo GJ; Farrah JP; Borgerding EM; Stirparo JJ; Lauer C; Kilgo P; Miller PR Am Surg; 2015 Jun; 81(6):605-9. PubMed ID: 26031274 [TBL] [Abstract][Full Text] [Related]
15. Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer? Kopelman TR; O'Neill PJ; Pieri PG; Salomone JP; Hall ST; Quan A; Wells JR; Pressman MS Am J Surg; 2013 Dec; 206(6):911-5; discussion 915-6. PubMed ID: 24296098 [TBL] [Abstract][Full Text] [Related]
16. Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient. Bickford A; Majercik S; Bledsoe J; Smith K; Johnston R; Dickerson J; White T Am J Surg; 2013 Dec; 206(6):847-51, discussion 851-2. PubMed ID: 24070664 [TBL] [Abstract][Full Text] [Related]
17. Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients. Ludwig KP; Simons HJ; Mone M; Barton RG; Kimball EJ Ann Pharmacother; 2011 Nov; 45(11):1356-62. PubMed ID: 22009998 [TBL] [Abstract][Full Text] [Related]
18. Enoxaparin dosing after cesarean delivery in morbidly obese women. Overcash RT; Somers AT; LaCoursiere DY Obstet Gynecol; 2015 Jun; 125(6):1371-1376. PubMed ID: 26000508 [TBL] [Abstract][Full Text] [Related]
19. Trauma patients with lower extremity and pelvic fractures: Should anti-factor Xa trough level guide prophylactic enoxaparin dose? Dhillon NK; Smith EJT; Gillette E; Mason R; Barmparas G; Gewertz BL; Ley EJ Int J Surg; 2018 Mar; 51():128-132. PubMed ID: 29367044 [TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics Associated With Higher Enoxaparin Dosing Requirements for Venous Thromboembolism Prophylaxis in Trauma Patients. Hashim YM; Dhillon NK; Veatch JM; Barmparas G; Ley EJ Am Surg; 2021 Jul; 87(7):1177-1181. PubMed ID: 33342267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]